Five-Year Examination of Utilization and Drug Cost Outcomes Associated with Benefit Design Changes Including Reference Pricing for Proton Pump Inhibitors in a State Employee Health Plan
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.